Pelago Bioscience is proud to participate in the LRIG Philadelphia Annual Vendor Exhibition. This event brings together scientists, researchers, and technology leaders to explore the latest innovations in laboratory automation and drug discovery.
Meet Our Team
Stephen Kosteski (Senior Business Development Director) will present how CETSA® technology enables quantification of target engagement in intact cells—providing meaningful data under physiologically relevant conditions.
Presentation Details
Title: CETSA – Cellular Thermal Shift Assay for assessment and quantification of target engagement in cellular environments under actual physiological conditions
Presenter: Stephen Kosteski
Time: 7:10 PM (15 minutes)
Why Attend?
Learn how CETSA can provide direct evidence of compound-target interaction in live cells, offering a powerful approach to evaluating compound efficacy, selectivity, and mechanism of action early in the drug discovery process.
Whether looking to assess target engagement, validate hits, or prioritize compounds, CETSA delivers biologically relevant insights that traditional in vitro methods often miss.
Connect with Us
If you’re attending LRIG Philadelphia, join Steve’s presentation. We look forward to discussing how Pelago Bioscience can support your drug discovery goals.
For more details about the event, visit Philly LRIG Annual Vendor Exhibition 2025.